Hospital Sant Joan de Déu Barcelona
Hospital Sant Joan de Déu Barcelona
Espagne, Barcelone
Uniquement pour les enfants et adolescents (0-18 ans)
Jaume Mora Graupera
30 années d'expérience
accréditations :
La clinique est certifiée :
Le coût du traitement du gliome en Espagne varie en fonction du plan de traitement choisi. Une consultation initiale avec un neurochirurgien coûte environ 470 €, tandis que les diagnostics préopératoires, y compris les IRM et les scanners PET, varient de 2 540 € à 4 140 €. La procédure neurochirurgicale, qui implique une neuronavigation avancée et une résection guidée par fluorescence, est estimée entre 46 030 € et 51 690 €. De plus, l"imagerie postopératoire peut augmenter le coût total, avec des images au prix d"environ 1 220 €. Les séances de réhabilitation varient de 94 € à 160 € chacune. Le plan de traitement final et les coûts sont déterminés après l"évaluation d"un spécialiste.
Le Dr Javier Herrero Jover est un pionnier de la planification chirurgicale en 3D, apportant plus de 30 ans d'expertise au Centro Médico Teknon.
Le Dr Bartolome Oliver est un pionnier de la neurochirurgie mini-invasive, ayant réalisé plus de 900 traitements de tumeurs cérébrales avec des techniques avancées.
Le Dr Graupera a mis au point un traitement passif pour les gliomes de la moelle épinière sans radiothérapie – une percée en oncologie pédiatrique. Il dirige le département d'hématologie et d'oncologie de Sant Joan De Déu.
Pionnier dans la définition de critères stricts pour les syndromes neurologiques paranéoplasiques – le Dr Graus est une figure de proue de la neuro-oncologie à l'Hospital Quiron Barcelona.
Patients choose Spain for glioma treatment to access advanced neuro-oncology protocols like fluorescence-guided surgery and Tumor Treating Fields. Spanish centers provide faster access to urgent interventions. JCI-accredited facilities in Barcelona and Madrid offer specialized care from neurosurgeons with over 40 years of experience.
Bookimed Expert Insight: Data shows Spain is a top destination for complex neurosurgery, ranking 3rd globally in our network. While many focus on surgery, the real value is in the integrated diagnostics. For example, packages at Hospital Ruber Internacional include PET-CT and angiography alongside surgery. This comprehensive approach often saves patients 7-10 days in the critical planning phase.
Patient Consensus: Patients note that avoiding long wait times for biopsies and imaging is a primary motivator. Many emphasize that the ability to secure online consultations within 24 hours provides vital peace of mind when facing urgent tumor progression.
Top-rated hospitals for glioma treatment in Spain include Centro Medico Teknon, Hospital Ruber Internacional, and Clinica Universidad de Navarra. These JCI-accredited centers specialize in fluorescence-guided resection. They utilize advanced technologies like Gamma Knife and TrueBeam to maximize tumor removal while preserving neurological function.
Bookimed Expert Insight: While hospital reputation is important, our data reveals that specialized neuro-oncology packages often include vital diagnostics like PET-CT and MRI. For instance, Hospital Ruber Internacional offers a $35,000 comprehensive Gamma Knife package, whereas Teknon provides targeted radiosurgery for $16,000. Choosing based on the specific neurosurgeon’s annual glioma volume often ensures better functional outcomes after complex resections.
Patient Consensus: Patients emphasize finding a hospital with a dedicated multidisciplinary tumor board. They note that quick response times for second opinions and fast MRI scheduling are essential for managing aggressive brain tumors.
Spain is a top European neuro-oncology hub. Facilities offer Gamma Knife radiosurgery, MR-Linac guided therapies, and awake craniotomies for gliomas. Specialized centers utilize fluorescence-guided surgery to maximize tumor resection. Patients can access innovative dendritic cell vaccines and genetic trials for glioblastoma treatment.
Bookimed Expert Insight: While standard treatments are widely available, the infrastructure in Spain allows for faster access to radiosurgery. For instance, Hospital Ruber Internacional and Centro Médico Teknon report high volumes for Gamma Knife and Truebeam. This suggests centers prioritize non-invasive options for early-stage or deep-seated tumors. Patients often save time by coordinating diagnostics like PET-CT and MRI in 1-day bundles at these clinics.
Patient Consensus: Patients emphasize the value of getting a second opinion from major university hospitals. They note that having full molecular profiling for markers like IDH and MGMT is essential for qualifying for the latest targeted trials.